Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Tianyin Pharmaceutical Co. Inc.
Fiscal year is July-June. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 63.94M 95.2M 69.61M 67.5M 46.56M
Cost of Goods Sold (COGS) incl. D&A 30.59M 52.7M 45.27M 41.5M 29.15M
COGS excluding D&A 29.64M 51.51M 44.06M 39.06M 26.56M
Depreciation & Amortization Expense 953,767 1.19M 1.22M 2.44M 2.59M
Depreciation 518,573 544,679 512,381 1.63M -
Amortization of Intangibles 435,194 643,091 702,852 803,947 -
Gross Income 33.35M 42.5M 24.33M 26M 17.41M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 18.6M 24.43M 15.79M 16.69M 14.54M
Research & Development 852,848 1.07M 860,081 894,995 946,300
Other SG&A 17.75M 23.36M 14.93M 15.79M 13.6M
Other Operating Expense 0 0 0 0 -
Unusual Expense 0 (1.63M) 0 0 -
EBIT after Unusual Expense 0 1.63M 0 0 -
Non Operating Income/Expense (39,518) 0 189,268 0 (3.07M)
Non-Operating Interest Income 0 132,766 209,037 162,563 165,533
Equity in Affiliates (Pretax) - - - 0 -
Interest Expense 25,649 119,507 331,334 437,897 392,010
Gross Interest Expense 25,649 119,507 331,334 437,897 392,010
Interest Capitalized 0 0 0 0 -
Pretax Income 14.68M 19.71M 8.61M 9.04M (432,121)
Income Tax 2.63M 4.09M 2.37M 2.42M 0
Income Tax - Current Domestic - 4.09M - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - - - - -
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - - - - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 -
Consolidated Net Income 12.05M 15.62M 6.24M 6.62M (432,121)
Minority Interest Expense 11,677 (40,243) (116,772) (56,978) (163,115)
Net Income 12.04M 15.66M 6.36M 6.67M (269,006)
Extraordinaries & Discontinued Operations 0 0 0 0 -
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 -
Cumulative Effect - Accounting Chg 0 0 0 0 -
Discontinued Operations 0 0 0 0 -
Net Income After Extraordinaries 12.04M 15.66M 6.36M 6.67M (269,006)
Preferred Dividends 489,649 143,019 0 0 -
Net Income Available to Common 11.55M 15.52M 6.36M 6.67M (269,005)
EPS (Basic) 0.47 0.55 0.22 0.23 (0.01)
Basic Shares Outstanding 24.43M 28.4M 29.31M 29.34M 29.43M
EPS (Diluted) 0.40 0.53 0.22 0.23 (0.01)
Diluted Shares Outstanding 30.08M 29.74M 29.31M 29.34M 29.43M
EBITDA 15.7M 19.26M 9.76M 11.75M 5.45M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.